Effect of Smart Phone Health Education on Overweight and Obese Schoolchildren's Dietary Habits and Body Composition
mHealth
Effect of Smart Phone Delivered Health Education Intervention on Overweight and Obese Schoolchildren's Dietary Habits and Body Composition in the UAE
2 other identifiers
interventional
146
1 country
1
Brief Summary
The aim of this study is to investigate the effect of mobile health nutrition education intervention in the changing of dietary habits and body composition of overweight and obese 8-12 years old children in Sharjah, United Arab Emirates and to compare its effectiveness to paper educational intervention among the same age group. The main questions it aims to answer are:
- 1.Are there any significant changes in dietary habits, physical activity and body composition among overweight and obese school-age children after three months of mobile health intervention?
- 2.Is there any significant difference between the effect of smart phone delivered and paper delivered interventions (changes in dietary habits, physical activity and body composition) among overweight and obese school-age children after three months of interventions?
- 3.Are there any significant changes in the obesity inflammatory panel among overweight and obese school-age children after three months of mobile health intervention?
- 4.Is there any significant difference in the sustainability of the outcomes between mobile health and paper delivered interventions among overweight and obese school-age children two months after the end of the intervention?
- 5.Are there any significant changes in nutrition related knowledge among parents of overweight and obese school-age children after three months of intervention?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 7, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2024
CompletedMay 14, 2024
May 1, 2024
3 months
January 7, 2024
May 11, 2024
Conditions
Outcome Measures
Primary Outcomes (19)
Weight
Will be measured using a Body Composition Analyzer, and will be measured in Kilograms
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Height
Will be measured using a standing Stadiometer, and will be measured in Centimetres
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Body Mass Index
Will be calculated using the weight and height, and will be measured in kg/m\^2
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Body Fat Mass
Will be measured using a Body Composition Analyzer, and will be measured in Kilograms
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Fat Free Mass
Will be measured using a Body Composition Analyzer, and will be measured in Kilograms
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Total Body Water
Will be measured using a Body Composition Analyzer, and will be measured in Kilograms
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Parents' Knowledge
Using a valid Nutrition Knowledge Attitude Practice Questionnaire - no scale
twice: before intervention (at 0 months) and after intervention (at 3 months).
Children's Dietary Intake
Using 24 Hours' Diet recall (3 days).
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Children's Physical Activity
Using a valid Physical Activity Questionnaire - no scale
3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)
Salivary C-Reactive Protein Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Adiponectin (Acrp30) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Complement Factor D (Adipsin) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Interleukin 6 (IL-6) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Interleukin 10 (IL-10) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Leptin (OB) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Resistin Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Plasminogen Activator Inhibitor-1 (Serpin E1 / PAI-1) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Salivary Tumour Necrosis Factor alpha (TNF alpha) Concentration
Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)
twice: before intervention (at 0 months) and after intervention (at 3 months).
Study Arms (2)
Intervention group
EXPERIMENTALParticipants in the intervention group will receive smart phone delivered health education in the form of text messages through WhatsApp.
Control group
ACTIVE COMPARATORParticipants in the control group will receive paper delivered health education in the form of a one time handout.
Interventions
Nutrition and Health Education module delivered through m-health approach (smart phones)
Nutrition and Health Education module delivered through conventional approach (paper)
Eligibility Criteria
You may qualify if:
- Overweight/obese children (over 2 SD based on the WHO Growth Reference (2007)).
- Between 8 - 12 years old.
- Attending school in Sharjah, UAE.
You may not qualify if:
- Children on a specific diet.
- Children who have any chronic diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universiti Sains Malaysialead
- University of Sharjahcollaborator
Study Sites (1)
University of Sharjah
Sharjah city, United Arab Emirates
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Lab technician who will handle the saliva analysis and the person who will be doing the statistical analysis will be blinded of any data related to the grouping of the participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 7, 2024
First Posted
February 7, 2024
Study Start
December 1, 2023
Primary Completion
March 10, 2024
Study Completion
May 10, 2024
Last Updated
May 14, 2024
Record last verified: 2024-05